California reports pharma increased list prices way above inflation. (STAT Plus)

More reads

• California reports pharma increased list prices way above inflation. (STAT Plus)
• BioNTech sets terms for $251 million US IPO valuing immuno-oncology biotech at $4.5 billion. (Renaissance Capital)
• Survey finds 60 percent of Mass. biotech workers would change job to get a better commute. (Boston Globe)
• As tariffs affect the pharma industry, business strategies must evolve. (STAT)